Life Science Investing Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
Life Science Investing Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency
Life Science Investing Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
Life Science Investing AbbVie Announces Positive Topline Results from Phase 3 UP-AA Trial Evaluating Upadacitinib for Alopecia Areata
Life Science Investing AbbVie Submits for U.S. FDA Approval of Combination Treatment of VENCLEXTA® and Acalabrutinib for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Life Science Investing Adicet Bio Announces First Systemic Sclerosis Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
life science investing Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling
Life Science Investing Ichnos Glenmark Innovation and AbbVie Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
Life Science Investing AbbVie and Ichnos Glenmark Innovation Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody
Life Science Investing AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology
Allied Critical Metals Appoints General James A. "Spider" Marks as a Director of Allied Critical Metals USA, Its U.S. Subsidiary Focused on Tungsten Import and Sales
Questcorp Mining Completes 25 Percent of Maiden Drilling Program at the La Union Gold & Silver Project in Mexico
